Respire_final-01
  • CORPORATE
    • Company Overview
    • Board of Directors
    • RespireRx Organization Structure
    • Social Media Guidelines
  • NEUROTRANSMISSION
  • RESOLUTIONRX
    • Cannabinoid Platform Summary
    • Pharmaceutical Cannabinoids
    • Obstructive Sleep Apnea
    • Dronabinol for the Treatment of Obstructive Sleep Apnea
    • Regulatory Process
  • ENDEAVOURRX
    • Neuromodulators
    • Ampakines
      • AMPAkine Platform Summary
      • Lead Compounds
      • Attention Deficit Hyperactivity Disorder (ADHD)
      • Spinal Cord Injury (SCI)
    • GABAkines
      • GABAkines Platform Summary
      • Background
      • Epilepsy
      • Pain
  • PRODUCT PIPELINE
  • INVESTORS
    • Investor Contact
    • SEC Reports
    • News
    • FAQs
    • Presentations
  • CONTACT

Author: j3ff1

Home Articles Posted by j3ff1 (Page 4)
113 posts, 0 comments

4/22/2021 – RespireRx Pharmaceuticals Inc. Provides Update on Its Development Programs

April 22, 2021j3ff1
Read More

2/8/2021 – Corrected Headline: RespireRx Pharmaceuticals Up Listed to OTCQB and Ticker Returns to RSPI

February 8, 2021j3ff1
Read More

2/8/2021 – RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split

February 8, 2021j3ff1
Read More

1/8/2021 – RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences

January 8, 2021j3ff1
Read More

1/5/2021 – RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split

January 5, 2021j3ff1
Read More

RespireRx Corporate Slide Deck Q4 2020

December 17, 2020j3ff1
Read More

11/12/2020 – RespireRx November 2020 Slide Deck

November 12, 2020j3ff1
Read More

10/27/2020 – RespireRx Pharmaceuticals Inc. Announces Appointment of Dr. James Cook and Dr. Jeffrey Witkin as Research Fellows

October 27, 2020j3ff1
Read More

10/06/2020 – RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of Ampakines in the Treatment of Spinal Cord Injury

October 6, 2020j3ff1
Read More

09/25/2020 – RespireRx Pharmaceuticals Inc. Announces Appointment of David Dickason as Senior Vice President Pre-Clinical Product Development

September 25, 2020j3ff1
Read More

Posts navigation

< 1 2 3 4 5 6 7 … 12 >

RespireRx Organization Structure

  • RespireRx Organization Structure
  • Arnold S. Lippa, PhD
    • Richard Purcell
    • David Dickason
    • James Cook
    • Jeffrey M. Witkin
    • Rok Cerne
  • Jeff Margolis
©2016 RespireRx Phamaceuticals Inc. All Rights Reserved.